Voluntary Medical Male Circumcision as part of the National Program and the Combination Prevention Project in Botswana | CDC RFA GH15 150603CONT17

Opportunity Information: Apply for CDC RFA GH15 150603CONT17

This grant opportunity is a continuation funding announcement from the U.S. Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), under the Center for Global Health (CGH). It is titled "Voluntary Medical Male Circumcision as part of the National Program and the Combination Prevention Project in Botswana" and is focused on supporting health activities in Botswana that use voluntary medical male circumcision (VMMC) as a core HIV prevention intervention within a broader combination prevention approach. In practical terms, the opportunity is about sustaining and advancing an existing program effort rather than starting a brand-new initiative, aligning VMMC service delivery with Botswana's national program priorities and with coordinated prevention strategies that typically include multiple, reinforcing interventions.

The announcement is identified by Funding Opportunity Number CDC RFA GH15-150603CONT17 and is categorized specifically as a continuation opportunity. The funding instrument type is a cooperative agreement, which generally means the CDC anticipates having substantial involvement in the work beyond simply providing funds. Cooperative agreements commonly involve ongoing technical collaboration, joint planning, performance monitoring, and programmatic oversight between the recipient and CDC staff. The activity category is Health, and the CFDA number listed is 93.067, which corresponds to CDC global health assistance programming and helps classify the award within federal assistance listings.

The goal implied by the title and description is to support implementation of VMMC as part of Botswana's national HIV prevention framework and as a component of the Combination Prevention Project. VMMC is widely used in HIV prevention portfolios because evidence has shown it can reduce the risk of heterosexually acquired HIV infection in men, and many national HIV responses in Southern Africa have incorporated it as one element in a layered prevention strategy. The "combination prevention" framing signals that circumcision services are intended to be integrated with other prevention and sexual health services rather than delivered in isolation, typically emphasizing coordinated outreach, demand creation, linkage to testing and treatment services, and quality clinical delivery consistent with national standards.

Eligibility is listed as "Others," with further clarification indicated as being available in an "Additional Information on Eligibility" section in the full notice. That phrasing usually suggests that eligibility may be limited to specific organizations already engaged in the program, entities meeting certain technical or geographic criteria, or particular partner types such as non-governmental organizations, academic institutions, or other implementing partners with demonstrated capacity in HIV prevention programming. Because this is a continuation opportunity, it often implies that the eligible pool may be narrower than an open competition, potentially favoring current recipients or organizations already working in the relevant portfolio, although the exact scope would depend on the detailed eligibility language in the full announcement.

Key administrative details include a creation date of February 17, 2017, and an original closing date of April 18, 2017, which defines the application window for that cycle. The CDC indicated an expectation of 10 awards, suggesting multiple implementers or multiple supported components under the overall VMMC and combination prevention effort. The award ceiling is listed as 0, which commonly indicates that a specific maximum funding cap was not stated in the summary fields, that the ceiling may be defined elsewhere in the full solicitation, or that the ceiling is variable depending on the approved scope, available funds, and negotiated work plans typical of cooperative agreements.

Overall, this opportunity is best understood as CDC support for continued, coordinated scale-up or maintenance of voluntary medical male circumcision services in Botswana as a central prevention intervention, delivered under national program leadership and integrated within a broader combination prevention strategy. The cooperative agreement structure and continuation category both point to an implementation-focused award where the CDC is likely to remain closely engaged in technical guidance, monitoring, and alignment with program goals and national HIV prevention priorities.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Voluntary Medical Male Circumcision as part of the National Program and the Combination Prevention Project in Botswana" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 17, 2017.
• Applicants must submit their applications by Apr 18, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 150603CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: